4 expert articles on medical innovation
The FDA approval of Casgevy for sickle cell disease marked a historic milestone — the first CRISPR therapy approved anywhere in the world.
Read Article →Researchers have printed functional heart muscle, ear cartilage, skin grafts, corneas, and miniature livers used for drug testing — and full organs are within sight.
Read Article →FDA-cleared powered exoskeletons are enabling paralyzed patients to stand and walk — with outcomes data showing neuroplasticity-driven improvements that persist after device removal.
Read Article →Stem cell therapy sits at an awkward intersection: extraordinary scientific promise, regulatory challenges, fraudulent clinics — and genuine clinical breakthroughs.
Read Article →